Post-COVID-19 Syndrome Clinical Trial
Official title:
Associated Factors for Impaired Lung Function in Post-COVID Nursing Home Residents
Verified date | May 2023 |
Source | University of Vic - Central University of Catalonia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The coronavirus disease 2019 (COVID-19) took a toll in institutionalised older adults, who represent a vulnerable population in European countries. The aim of this study is to identify the predictive factors that worsens lung function in post-COVID nursing home (NH) residents. This is a multicenter case-control study in nursing homes of Osona (Catalonia), where individuals with worsened (cases) and normal (controls) lung function will be studied. The inclusion criteria are: female and male from 65 to 95 years old, preserved cognitive capacity and positive diagnosis of COVID-19 at least 3 months prior. We will assess sociodemographic variables, lung function [spirometry], fatigue [Chalder Fatigue Scale], frailty [Clinical Frailty Scale], and activities of daily living (ADL) [modified Barthel index].
Status | Enrolling by invitation |
Enrollment | 150 |
Est. completion date | January 30, 2024 |
Est. primary completion date | November 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years to 95 Years |
Eligibility | Inclusion Criteria: - male and female - preserved cognitive function - previous positive diagnosis of COVID-19 at a minimum of 3 months to the day of data collection - individuals living permanently in a nursing home Exclusion Criteria: - individuals in coma or palliative care - any contraindication to perform spirometry (severe hypertension, myocardial infarction in the past week, non compensated heart failure, etc). |
Country | Name | City | State |
---|---|---|---|
Spain | Faculty of Health Sciences and Welfare | Vic | Barcelona |
Lead Sponsor | Collaborator |
---|---|
University of Vic - Central University of Catalonia | Catalan Board of Physiotherapists |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Lung function | Lung function will be assessed by spirometry. | Through study completion, an average of 1 year | |
Secondary | Sociodemographic variables | Sociodemographic variables (age, gender, length of institutionalization) will be collected through an interview. | Through study completion, an average of 1 year | |
Secondary | Anthropometric variables | Anthropometric variables (weight and height) will be collected by means of a scale and a measuring tape, respectively. | Through study completion, an average of 1 year | |
Secondary | Health variables | Health variables (history of comorbidities) will be collected directly in the medical records of each participant. | Through study completion, an average of 1 year | |
Secondary | COVID-19 variables | The following variables related to COVID-19 will be collected from the medical records of each participant: diagnostic tests (PCR and serological test), suspicious case (symptoms of cough, fever, difficulty breathing, etc.), previous hospitalization for COVID-19 (yes/no, duration), use of mechanical ventilation during hospitalization (yes/no, duration) and vaccination (yes/no, type). | Through study completion, an average of 1 year | |
Secondary | Fatigue | Fatigue levels will be collected using the Chalder Fatigue Scale (CFQ-11) | Through study completion, an average of 1 year | |
Secondary | Frailty | Frailty levels will be assessed using the Clinical Frailty Scale (CFS). | Through study completion, an average of 1 year | |
Secondary | Dependency levels | Dependency levels will be assessed using the Barthel modified index. | Through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06073002 -
Effects of a Home-Based Exercise Intervention in Subjects With Long COVID
|
N/A | |
Completed |
NCT05047952 -
Vortioxetine for Post-COVID-19 Condition
|
Phase 2 | |
Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
Recruiting |
NCT06091384 -
Inspiratory Muscle Strength Training in Post-Covid Syndrome
|
N/A | |
Not yet recruiting |
NCT06267300 -
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
|
Phase 3 | |
Recruiting |
NCT05986422 -
Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
|
Phase 2 | |
Not yet recruiting |
NCT05534997 -
Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT05638633 -
Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
|
Phase 3 | |
Active, not recruiting |
NCT05630040 -
VNS for Long-COVID-19
|
N/A | |
Recruiting |
NCT05841498 -
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
|
N/A | |
Enrolling by invitation |
NCT05981872 -
EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19
|
N/A | |
Active, not recruiting |
NCT05543408 -
Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"
|
N/A | |
Recruiting |
NCT05817032 -
Effect of Telerehabilitation Practice in Long COVID-19 Patients
|
N/A | |
Recruiting |
NCT05823896 -
imPROving Quality of LIFe In the Long COVID Patient
|
Phase 2 | |
Completed |
NCT05764070 -
Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post SARS-CoV-2 Patients
|
N/A | |
Completed |
NCT05765591 -
Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome
|
N/A | |
Recruiting |
NCT05918965 -
Vagus Stimulation in Female Long COVID Patients.
|
N/A | |
Not yet recruiting |
NCT06231238 -
Balance Acceptance and Commitment Therapy for Long COVID
|
Phase 2 | |
Completed |
NCT06282627 -
The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients
|
||
Completed |
NCT05648734 -
Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis
|